Study Participants Needed
PHOENIX - Officials at the Arizona Research Center are searching for two trials of ALT-711 - an investigational drug used to reverse the effects of hypertension.
There are more than 60 testing sites nationally. Patients recruited will receive ALT-711 tablets or placebo one a day for six months.
To qualify, patients must be 50 years old or older, and have a systolic blood pressure of at least 150 mmHg and a diastolic blood pressure of less than 90 mmHg. Both male and female, diabetic and non-diabetic participants are being recruited.
For more information, contact Brook Irving at: 9602) 863-6363.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
